Logo

NCI Awards $10M to Six US Labs Researching Cancer Biomarkers

Nov 28, 2005

NEW YORK, Nov. 28 (GenomeWeb News) - The National Cancer Institute awarded a total of $10 million to six research groups developing molecular markers for cancer, the agency said today.

 

The projects will confirm, refine, and evaluate molecular signatures; develop reproducible assays for molecular signatures; and identify molecular markers to be used in clinical decisions.

 

The grants are part of NCI's Strategic Partnering to Evaluate Cancer Signatures program.

 

Six institutions received the grant: the Children's Hospital in Los Angeles, Calif., University of California in Irvine; the University of Nebraska Medical Center in Omaha; the University of New Mexico in Albuquerque; Vanderbilt-Ingram Cancer Center in Nashville, Tenn.; and Washington University's Department of Medicine in St. Louis.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.